Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Apheris is seeking an ML Engineer to advance our large molecule ML programs in antibody modeling, co-folding and developability. You will translate research prototypes into production-ready models that run in federated pharma data environments.
Join a hands-on team at the intersection of biology and foundation models, tackling drug discovery challenges with scalable ML, rigorous evaluation, and cross-functional collaboration.
AtApheris, we are building the future of how AI is applied in pharmaceutical R&D.
We enable leading pharmaceutical teams to discover and develop drugs faster. We host the industry’s largest federated data networks for drug discovery AI, spanning co-folding, ADMET, and antibody developability.
Across these networks, models are trained on proprietary industry datasets to achieve higher performance and broader applicability while keeping data control and IP protected. We deliver these superior models through drug discovery applications that enable teams to run them at scale, further customize them, and integrate them into existing R&D workflows.
We are looking for an ML Engineer to join our large molecule ML team and build the models behind our antibody, co-folding and developability programs.
This is a hands-on role at the intersection of foundation models, structural biology, protein engineering and federated learning. You will build, train and evaluate ML systems for antibody modeling, co-folding, developability prediction and biologics discovery, working on proprietary pharma data across our federated networks.
You will own substantial parts of our model programs end to end. That means taking research-led or open-source prototypes and turning them into models that can be evaluated, released and used in real drug discovery workflows.
You're an ML engineer who works close to the science. You've trained and evaluated models on biological data, and you can take a paper or an open-source model and make it work on a new problem.
You care about whether a model actually holds up, not just whether the numbers look good, and you want your work to end up in real use by pharma R&D teams.